Novel HER2 targeting immunotherapeutics for breast cancer

Ended Project Grant Awarded Last action

Award ID
R43AI081465
Recipient
Awarding agency
Obligated
$500,128

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Place of performance
Chicago, IL 60612, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $269,083
Original award $231,045

Quick answers

Who received award R43AI081465?

R43AI081465 was awarded to Iterative Therapeutics Inc. by National Institutes of Health (Department of Health and Human Services) on May 1, 2010.

How much is award R43AI081465 worth?

$500,128 has been obligated on R43AI081465.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award